InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
25%
T+90 mean return
-4.6%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the complete record of transactions filed by Mathers Edward T, Director. Director active across 7 companies, notably Monte Rosa Therapeutics, Inc.. Cumulatively, 9 reports have been logged. Split: 2 buys · 0 sell. Total volume traded: €1.8m. History available since 11 April 2022. The latest transaction was disclosed on 31 March 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
2,580 shares0Class A Common StockSEC:0000950170-25-049473:0
1,023,103 sharesCommon StockSEC:0000950170-24-107558:0
3,000 sharesCommon StockSEC:0000950170-24-077346:0
17,857 shares@ US$56.00100.0% of flowCommon StockSEC:0000950170-24-047681:0
Ideal exit: 17 Jan 2025 (T+270)
333,333 shares@ US$3.00100.0% of flowCommon StockSEC:0001209191-23-042802:0
Ideal exit: 12 Apr 2024 (T+270)
5,771 shares0Common StockSEC:0001209191-23-016175:0
948,948 shares@ US$1.900.082% mcap100.0% of flowCommon StockSEC:0001209191-22-024323:0
2,715,968 sharesCommon StockSEC:0001209191-21-044044:0
2,715,968 sharesCommon StockSEC:0001209191-21-044044
9 of 9 declarations
About Mathers Edward T
Mathers Edward T is a Board Member of Monte Rosa Therapeutics, Inc. and Trevi Therapeutics, Inc. With experience in the biopharmaceutical sector, he plays a key role in overseeing operations and the development strategy of the companies. Edward is recognized for his expertise in research and development, contributing to innovation and growth.
